# US 2008/0269889 A1 · Haptic Junction Designs to Reduce Negative Dysphotopsia

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2008/0269889 A1
- Document ID: US20080269889A1
- Status: Published application
- Kind: A1
- Application number: 11/741,818
- Filed: 2007-04-30
- Published: 2008-10-30
- Earliest claimed: 2007-04-30
- Inventors: Michael J. Simpson
- Web page: https://patentgrep.com/patent/US20080269889A1

## CPC

- A61F 2/1656: {Fresnel lenses, prisms or plates}
- A61F 2/1613: {having special lens configurations, e.g. multipart lenses; having particular optical properties, e.g. pseudo-accommodative lenses, lenses having aberration corrections, diffractive lenses, lenses for variably absorbing electromagnetic radiation, lenses having variable focus}
- A61F 2002/0081: {directly machined on the prosthetic surface, e.g. holes, grooves (A61F2/30771 takes precedence)}
- A61F 2002/1683: {having filiform haptics}
- A61F 2002/1699: {Additional features not otherwise provided for}
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)

## Abstract

Methods and devices for inhibiting the dark shadow effect, known as dysphotopsia, perceived by some subjects having implanted intraocular lenses (IOLs) are presented. In one aspect, an IOL can include an optic and one or more fixation members for facilitating placement of the IOL. The fixation member can be adapted to have a portion that redirects light that is incident thereon in a manner which alleviates or prevents dysphotopsia. For example, the light that is incident on a fixation member can be directed to a retinal location intermediate to where imaging typically occurs on the retina and where a secondary image is formed. Various techniques for achieving these improvements are discussed, both in terms of the structures of improved IOLs, and methods for alleviating dysphotopsia.

## Claims

### Claim 1

An intraocular lens (IOL), comprising:
a) an optic for implantation in an eye of a subject;
b) at least one fixation member coupled to the optic for facilitating placement of the optic in the eye; and
c) a light-directing element located between the fixation member and the optic, the light-directing element directing light rays incident thereon so as to inhibit perception of visual artifacts in the subject's visual field when the IOL is implanted in the subject's eye.

### Claim 2 (depends on 1)

The IOL of claim 1, wherein the light-directing element is positioned on a nasal side of the eye.

### Claim 3 (depends on 1)

The IOL of claim 1, wherein, upon implantation in the subject's eye, the optic is adapted to form an image of a field of view on a retina of the subject's eye, and the light-directing element is adapted to direct at least some light rays incident thereon to at least one retinal location offset from the image.

### Claim 4 (depends on 3)

The IOL of claim 3, wherein the light-directing element comprises a posterior surface and an anterior surface, at least one of the posterior and anterior surfaces being adapted to direct light rays to the at least one retinal location offset from the image.

### Claim 5 (depends on 1)

The IOL of claim 1, wherein the light-directing element comprises at least one Fresnel lens.

### Claim 6 (depends on 1)

The IOL of claim 1, wherein the light-directing element comprises a diffractive structure.

### Claim 7 (depends on 1)

The IOL of claim 1, wherein the light-directing element comprises a refractive structure.

### Claim 8 (depends on 1)

The IOL of claim 1, wherein the light-directing element comprises at least one of a diffusive structure and a scattering structure.

### Claim 9 (depends on 1)

The IOL of claim 1, wherein the light-directing element comprises at least one of a lenslet and a zonal region.

### Claim 10 (depends on 1)

The IOL of claim 1, wherein the optic provides a first focusing power, and the light-directing element provides a second focusing power that is less than the first focusing power.

### Claim 11 (depends on 1)

The IOL of claim 1, wherein the IOL is adapted to be deformable to facilitate delivery of the IOL to the subject's eye.

### Claim 12 (depends on 1)

The IOL of claim 1, wherein the light-directing element forms at least a portion of a connecting junction between the optic and the at least one fixation member.

### Claim 13 (depends on 1)

A method of inhibiting dysphotopsia in a patient having an implanted IOL, comprising:
implanting the IOL of claim 1 in the patient.

### Claim 14

A deformable intraocular lens (IOL), comprising:
a) an optic for implantation in an eye of a subject, the optic adapted to form an image of a field of view on a retina of the subject;
b) at least one haptic coupled to the optic for facilitating placement of the IOL in the subject's eye; and
c) a junction region between the at least one haptic and the optic, wherein the junction region is adapted to direct light rays to at least one retinal location offset from the image so as to inhibit dysphotopsia.

### Claim 15 (depends on 14)

The IOL of claim 14, wherein the junction region is adapted to direct some light rays entering from a temporal side of the eye to the at least one retinal location offset from the image.

### Claim 16 (depends on 14)

The IOL of claim 14, wherein the optic provides a first focusing power, and the junction region comprises at least one portion providing a second focusing power less than the first focusing power.

### Claim 17 (depends on 14)

The IOL of claim 14, wherein the junction region comprises at least one Fresnel lens adapted to direct light rays to the at least one retinal location offset from the image.

### Claim 18 (depends on 14)

The IOL of claim 14, wherein the junction region comprises a diffractive structure adapted to direct light rays to the at least one retinal location offset from the image.

### Claim 19 (depends on 14)

The IOL of claim 14, wherein the junction region comprises a refractive structure adapted to direct light rays to the at least one retinal location offset from the image.

### Claim 20 (depends on 14)

The IOL of claim 14, wherein the junction region comprises at least one of a diffusive structure and a scattering structure adapted to direct light rays to the at least one retinal location offset from the image.

### Claim 21 (depends on 14)

The IOL of claim 14, wherein the junction region comprises at least one of a lenslet and a zonal region adapted to direct light rays to the at least one retinal location offset from the image.

### Claim 22 (depends on 14)

A method of inhibiting dysphotopsia in a patient having an implanted IOL, comprising the step of implanting the IOL of claim 14 in the patient.

### Claim 23

A method of inhibiting dysphotopsia in a patient, comprising the step implanting into the patient an IOL with at least one fixation member adapted to redirect at least some light rays incident thereon to a retinal location between an image formed by the IOL and a secondary peripheral image formed by peripheral rays entering the eye that miss the IOL.

### Claim 24 (depends on 23)

The method of claim 23, the step of redirecting light rays includes diffracting light rays that strike at least a portion of the at least one fixation member.

### Claim 25 (depends on 23)

The method of claim 23, the step of redirecting light rays includes refracting light rays that strike at least a portion of the at least one fixation member.

### Claim 26

An intraocular lens (IOL), comprising:
a) an optic adapted for placement in a patient's eye so as to form an image of a field of view; and
b) at least one fixation member coupled to the optic for facilitating placement thereof in the eye, the fixation member including at least a portion adapted to receive light rays entering the eye and directing such rays to a retina of the eye so as to inhibit dysphotopsia.

### Claim 27 (depends on 26)

The IOL of claim 26, wherein the at least one fixation member is positioned on a nasal side of the eye.

### Claim 28 (depends on 26)

The IOL of claim 26, wherein the portion of the at least one fixation member comprises a junction region connecting the at least one fixation member to the optic.

### Claim 29 (depends on 26)

The IOL of claim 26, wherein the optic has a first focusing power, and the at least one fixation member has at least a portion with a second focusing power less than the first focusing power.

### Claim 30 (depends on 26)

The IOL of claim 26, wherein the portion of the at least one fixation member comprises a diffractive structure for directing the light rays to at least one retinal location offset from the location at which the image is formed.

### Claim 31 (depends on 26)

The IOL of claim 26, wherein the portion of the at least one fixation member comprises a Fresnel lens for directing the light rays to at least one retinal location offset from the location at which the image is formed.

### Claim 32 (depends on 26)

The IOL of claim 26, wherein the IOL is adapted to be deformable to facilitate delivery of the IOL to the patient's eye.

### Claim 33 (depends on 29)

A method of inhibiting dysphotopsia in a subject requiring the implantation of an IOL, comprising the step of implanting the IOL of claim 29 in the subject.

### Claim 34

An intraocular lens (IOL), comprising:
a) an optic adapted for placement in a patient's eye so as to form an image of a field of view;
b) at least one fixation member coupled to the optic for orienting the optic in the patient's eye; and
c) a diffractive structure disposed on a surface of the fixation member.

### Claim 35 (depends on 34)

The IOL of claim 34, wherein the optic provides a first focusing power, and the diffractive structure provides a second focusing power that is less than the first focusing power.

### Claim 36 (depends on 34)

The IOL of claim 34, wherein the IOL is adapted to be deformable to facilitate delivery of the IOL to the subject's eye.

### Claim 37 (depends on 34)

A method of inhibiting dysphotopsia in a subject requiring the implantation of an IOL, comprising the step of implanting the IOL of claim 34 in the subject.
